FDA Inspection 1257221 - CorneaGen - Boston - December 20, 2024

Record Details

This FDA Inspection record concerns CorneaGen - Boston, with an inspection on December 20, 2024, issued by the New England District Office, covering biologics.

Company: CorneaGen - Boston
Inspection Date: December 20, 2024
Product Type: Biologics
Office: New England District Office

Open in Dashboard

ID · 43ca6f6d-9fc0-4574-8a2c-ae5be00b98c8

Violation Codes2

21 CFR 1271.265(c)(2)21 CFR 1271.75(d)

Full citation text and observation details available on the Dashboard.